Clinical Trial Update: Plasma Exchange With Albumin in AMN Patients [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/Phase 3 trial evaluating plasma exchange with albumin in patients with Adrenomyeloneuropathy and Adrenoleukodystrophy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adrenoleukodystrophy
• Adrenomyeloneuropathy

Drugs mentioned

• plasma exchange with albumin (plasma exchange with albumin)

Snippet

Sponsor: Pujol, Aurora, M.D. | Conditions: Adrenomyeloneuropathy, Adrenoleukodystrophy | Phase 2, Phase 3 | Status: COMPLETED